This Webinar is part of the CEO Roadshow Webinar Series where we feature up and coming public and private companies that present unique or attractive long-term investment opportunities.
In this webinar, we will be joined by members of the management team from Stealth BioTherapeutics.
They trade on the NASDAQ Exchange under the ticker MITO.
Please click on the following links to register for any of our upcoming webinars.
Stealth BioTherapeutics is using ground-breaking research to repair damaged mitochondria, located in almost all cells and producing energy and performing other crucial functions, in an effort to treat currently diseases with now current treatments.
The company has its signature treatment, elamipretide, in the FDA approval process for various conditions, including: Barth Syndrome, dry AMD and Duchenne Muscular Dystrophy.
Contact CEOROADSHOW.COM
Mike Elliott
me@CEOROADSHOW.COM
Disclaimer
CEOROADSHOW content and productions are based on data obtained from sources we believe to be reliable but are not guaranteed as to the accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor.
Any opinions expressed in CEOROADSHOW content and productions, or other investor relations materials and presentations are subject to change. Neither CEOROADSHOW nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. All data and information are provided for informational or entertainment purposes only. CEOROADSHOW is not a registered broker-dealer or a registered investment advisor.
CEORoadshow.com is committed to providing our readers with useful information on publicly traded companies. CEORoadshow.com sometimes contracts with third parties or publicly traded companies and receives compensation from them in the form of cash as payment for publishing information and opinions about the company and the trading market for their securities.
CEORoadshow.com content should not be considered to be independent publications concerning the company. CEORoadshow was paid a fee by a Stealth BioTherapeutics for publication of this video interview.
Neither CEOROADSHOW.COM or any of its principals currently own or plan to own within 72 hours of publication any shares of the stocks mentioned in this video. For a full disclaimer please visit, CEOROADSHOW.COM/disclaimer.
#investing #stocks #stockmarket
